The Centro Hospitalar e Universitário de Coimbra is a Portuguese public healthcare complex located in Coimbra, Portugal.

During the past decade, HUC; Servico de Hematologia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "HUC; Servico de Hematologia" #1 collaborator was "Genentech, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "HUC; Servico de Hematologia" are "B-cell Lymphoma" (1 trials) and "Lymphoma, Large B-Cell, Diffuse" (1 trials). Many other conditions were trialed in "HUC; Servico de Hematologia" in a lesser frequency.

Most popular intervention types in "HUC; Servico de Hematologia" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "CHOP" (2 trials), "Bevacizumab" (1 trials), "Placebo" (1 trials), "Rituximab" (1 trials) and "rituximab [MabThera/Rituxan]" (1 trials). Other intervention names were less common.

The vast majority of trials in "HUC; Servico de Hematologia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "HUC; Servico de Hematologia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in HUC; Servico de Hematologia, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in HUC; Servico de Hematologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".